MARKET

ELUT

ELUT

Elutia Inc.
NASDAQ
0.8001
-0.0299
-3.60%
Closed 16:10 09/09 EDT
OPEN
0.8201
PREV CLOSE
0.8300
HIGH
0.9099
LOW
0.8000
VOLUME
33.50K
TURNOVER
0
52 WEEK HIGH
2.040
52 WEEK LOW
0.5000
MARKET CAP
35.44M
P/E (TTM)
0.6572
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ELUT last week (0831-0904)?
Weekly Report · 3d ago
Weekly Report: what happened at ELUT last week (0824-0828)?
Weekly Report · 08/31 09:21
Weekly Report: what happened at ELUT last week (0817-0821)?
Weekly Report · 08/24 09:21
Elutia Inc. Earnings Call Highlights Funding, NXT Outlook
TipRanks · 08/23 00:13
Elutia Divests SimpliDerm to Refocus on NXT-41x
TipRanks · 08/21 21:31
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Gain Therapeutics (GANX), Summit Therapeutics (SMMT) and Elutia (ELUT)
TipRanks · 08/18 13:30
Weekly Report: what happened at ELUT last week (0810-0814)?
Weekly Report · 08/17 09:21
Analysts Are Bullish on These Healthcare Stocks: Sensus Healthcare (SRTS), Elutia (ELUT)
TipRanks · 08/14 13:10
More
About ELUT
Elutia Inc. is a commercial-stage company developing proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. Its cardiovascular biomatrix portfolio spans pericardial closure, intracardiac tissue repair, and vascular reconstruction. In Cardiovascular, it sells its specialized porcine small intestine submucosa for use as an intracardiac and vascular patch, as well as for pericardial reconstruction. Its cardiovascular products are specifically designed to provide immediate structural support while promoting tissue regeneration, cellular infiltration, and natural integration over time. It is focused on developing NXT-41x, an antibiotic-eluting biomatrix designed to address post-operative infection. The NXT-41x product is designed to provide soft-tissue reinforcement while locally delivering antibiotics locally to inhibit bacterial colonization at the surgical site.

Webull offers Elutia Inc stock information, including NASDAQ: ELUT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ELUT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ELUT stock methods without spending real money on the virtual paper trading platform.